Juvenile idiopathic arthritis
Conditions
Interventions
Case series:Total glucosides of paeony (TGP) capsules
Sponsors
Department of Rheumatology and Immunology, Beijing Chilren's Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: (1) Patient's age is less than 18 years old. (2) Patients diagnosed with JIA in the Department of Rheumatology and regularly followed up. (3) Patients who have received total glycosides of peony monotherapy/combination therapy for the first time. (4) Background medications may include one oral NSAIDs, as well as no more than three combination immunosuppressants (methotrexate, leflunomide, hydroxychloroquine, sulfasalazine, cyclosporine, thalidomide, and mycophenolate), steroids, biologics, and tofacitinib. Note: Patients are those who have taken total glycosides of peony for the first time since the start of this study or have previously taken it, but have not taken it within 3 months of the screening period.
Exclusion criteria
Exclusion criteria: (1) Patients who are unable to sign a written informed consent form. (2) Patients who are allergic to research drugs. (3) Patients have advanced, severe, or life-threatening illnesses, any medical or mental conditions. (4) Other reasons have been determined by the researcher to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of adverse events/reactions during the 8-week medication period.; | — |
Countries
China
Contacts
Public ContactLI CAIFENG
Beijing Chilren's Hospital,Capital Medical University
Outcome results
None listed